Abstract:Solitary fibrous tumors WHO grade II and III (SFTs II/III) are rare mesenchymal neoplasia accounting for 0.4% of primary central nervous system tumors. SFTs II/III located in the sella turcica region are even rarer and, since the first case described in 1983, only 21 case reports of sellar/suprasellar SFTs II/III (ssSFTs II/III) have been described to this day. We aim to analyze ssSFTs II/III and to demonstrate that can be differentiated from non-functioning pituitary adenomas through pathological examination alone. We analyzed 20 case reports of ssSFTs II/III identified through PubMed and Google searches and a new unpublished case presented at Emory University. ssSFTs II/III are equally represented in both sexes, with 11 cases over 21 occurring in females and the mean age of onset at 46 years old. Clinically, ssSFTs II/III present with compression symptoms related to the tumor location. Headache, visual field defects, and anterior hypopituitarism-related symptoms are frequent chief complaints. As such, almost all cases of ssSFTs II/III had a pre-biopsy working diagnosis of non-functioning pituitary adenomas. The differentiation between SFTs II/III and pituitary adenomas based on imaging findings remains challenging, and surgical biopsies are necessary for a definitive diagnosis. ssSFTs II/III surgical reports describe a unifying trait of a highly vascular tumor adherent to the dura that bleeds profusely after resection. These characteristics are less consistent with a pituitary adenoma. The genetic hallmark of SFTs at all anatomical sites is paracentric inversions at 12q13, fusing the NAB2 and STAT6 genes, with consequent overexpression of STAT6. Pituitary adenomas lack this genetic signature. ssSFTs II/III have an overlapping presentation and similar imaging findings of pituitary adenomas, but different management and prognosis. Hence, it is crucial to include ssSFTs II/III among the pre-biopsy differential of sellar/suprasellar masses identified on imaging. Pathology confirmation is required to guide therapy.

Pathogenic Diagnosis of Sellar Mass: Be Cautious

Primary sellar melanocytic tumor mimicking hemorrhagic pituitary macroadenoma: Case report and literature review.

Diagnosis of Diseases in Sellar Region with MRI

Microsurgical Resection of Sellar Tumors Via Lateral Supraorbital Approach:Clinical Analysis of 20 Cases

Case report: Misdiagnosis of accessory spleen in the left adrenal region as an adrenal tumour after splenectomy

Sellar Schwannoma Masquerading as Giant Pituitary Adenoma: A Diagnostic Challenge

Gangliocytomas in the Sellar Region

Delays in Diagnosis of Pediatric Histologically Confirmed Sellar Germ Cell Tumors in China: A Retrospective Risk Factor Analysis

The Understanding of the Hazards Associtated with Biosy in the Patients with the Primary Malignant Bone Tumors

Case Report: Spindle Cell Sarcoma and Pituitary Adenoma in the Sella Region—a Rare Collision Tumor

Sellar hemangiopericytoma masquerading as pituitary adenoma: an overlooked intriguing case study unveiling a rare surgical conundrum

Classification of the masses in the pancreatic head and the discussion on the modalities of their diagnosis and management

Value of Mediastinoscopy in Diagnosis of Mediastinal Mass

Diagnosis and Microsurgical Treatment of Meningiomas in the Sellar Region

Path-01. Sellar Solitary Fibrous Tumors Who Grade Ii And Iii: Mimics Of Non-Functioning Pituitary Adenomas

Primary collision tumors of the sellar region: Experience from a single center

Diagnostic challenges from conflicting results of tests and imaging

A Case of McCune-Albright Syndrome Associated with Pituitary GH Adenoma: Therapeutic Process and Autopsy

Sellar, suprasellar, and parasellar masses: Imaging features and neurosurgical approaches

A Systematic Review of Sellar and Parasellar Brown Tumors: An Analysis of Clinical, Diagnostic, and Management Profiles

Analysis of Misdiagnosed Solitary Pulmonary Nodules in 18F-FDG PET/CT Imaging